AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)
- First Posted Date
- 2010-07-19
- Last Posted Date
- 2016-11-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT01165268
- Locations
- 🇺🇸
Profil Institute For Clinical Research, Inc., Chula Vista, California, United States
Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients
Completed
- Conditions
- Dyslipidemia
- First Posted Date
- 2010-07-16
- Last Posted Date
- 2012-01-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 268
- Registration Number
- NCT01164397
- Locations
- 🇲🇽
Research Site, San Luis Potosi, Mexico
Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis
Phase 3
Withdrawn
- Conditions
- Venous ThrombosisPulmonary Embolism
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-07-16
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 3000
- Registration Number
- NCT01164540
Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg
Phase 1
Completed
- Conditions
- Effect of FoodPharmacokinetics
- Interventions
- Drug: esomeprazole/ASA Fixed Dose Combination (FDC)
- First Posted Date
- 2010-07-16
- Last Posted Date
- 2010-12-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT01163630
- Locations
- 🇺🇸
Research Site, Oveland Park, Kansas, United States
Open Label Prostate Cancer Study
- First Posted Date
- 2010-07-14
- Last Posted Date
- 2016-01-12
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 64
- Registration Number
- NCT01162395
- Locations
- 🇬🇧
Research Site, Surrey, United Kingdom
Phase I, Exploratory, Single Centre, Single Oral Dose AZD9668 and Intravenous Microdose of [C14] AZD9668, Healthy Subject
- First Posted Date
- 2010-07-13
- Last Posted Date
- 2011-02-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 6
- Registration Number
- NCT01161355
- Locations
- 🇬🇧
Research Site, London, United Kingdom
Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2010-07-12
- Last Posted Date
- 2011-08-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 231
- Registration Number
- NCT01160679
- Locations
- 🇰🇷
Research Site, Seoul, Korea, Republic of
Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects
- First Posted Date
- 2010-07-09
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 42
- Registration Number
- NCT01159145
- Locations
- 🇯🇵
Research Site, Tokyo, Japan
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)
Phase 3
Completed
- Conditions
- Major Depressive DisorderDepression
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-07-05
- Last Posted Date
- 2014-04-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 319
- Registration Number
- NCT01157078
- Locations
- 🇮🇳
Research Site, Mysore, India
Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Dapagliflozin/Metformin
- First Posted Date
- 2010-07-02
- Last Posted Date
- 2012-06-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 18
- Registration Number
- NCT01156246
- Locations
- 🇸🇪
Research Site, Lulea, Sweden